Session Details

Session Details

03:45 PM - 05:30 PM - Ballroom 4

Masato Yamamoto - PhD, MD - University of Minnesota

Co-Chair

03:45 PM - 04:00 PM - Ballroom 4

Cesare Canepari - San Raffaele Telethon Institute for Gene Therapy

198: Lentiviral Gene Therapy to the Liver for Homozygous Familial Hypercholesterolemia (FH): Assessing the Best Vector Design

03:45 PM - 05:30 PM - Ballroom 4

Sébastien Levesque - Boston Children's Hospital

Co-Chair

04:00 PM - 04:15 PM - Ballroom 4

Denise Klatt - PhD - Boston Children's Hospital, Harvard Medical School

199: Alpha-Retrovirus-Based Virus-Like Particles for Efficient Gene Editor Delivery into Hematopoietic Stem Cells

04:15 PM - 04:30 PM - Ballroom 4

Michael Barry - PhD - Mayo Clinic

200: Structure Derived Insights into the Similarities and Differences in Coagulation Factor Binding to Species C and Species D Adenoviruses

04:30 PM - 04:45 PM - Ballroom 4

Ronnie Russell - PhD - Interius BioTherapeutics

201: Rational Design of a Detargeted Vesiculovirus Fusogen to Enable Targeted In Vivo Gene Delivery

04:45 PM - 05:00 PM - Ballroom 4

Patricia Devaux - PhD - Mayo Clinic

202: Engineering Single-Cycle Measles Vector for CRISPR/Cas9 Gene Editing

05:00 PM - 05:15 PM - Ballroom 4

Chris Wright - Ring Therapeutics

203: Anellovectors, a Gene Delivery Platform Based on Commensal Human Anelloviruses, Have the Potential to Evade the Immune System and Deliver DNA Payloads to a Broad Range of Tissues in a Redosable Manner

05:15 PM - 05:30 PM - Ballroom 4

Parinaz Aliahmad - PhD - Replicate Bioscience, Inc

204: Novel Self-Replicating RNA Vectors Broaden Therapeutic Window and Expand Use Outside of Vaccines